Enterprise Value
-11.78M
Cash
31.18M
Avg Qtr Burn
-4.81M
Short % of Float
0.26%
Insider Ownership
1.14%
Institutional Own.
4.70%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IMNN-001 (GEN-1) Details Ovarian cancer, Cancer | Phase 1/2 Data readout | |
ThermoDox Details Cancer, Liver cancer | Failed Discontinued |